BioLife Solns (NASDAQ:BLFS) just reported results for the second quarter of 2024.
- BioLife Solns reported earnings per share of -5 cents. This was above the analyst estimate for EPS of -14 cents.
- The company reported revenue of $28.33 million.
- This was 18.28% better than the analyst estimate for revenue of $23.95 million.